Cargando…
DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade
PURPOSE: Although meningiomas are common central nervous system tumors, the biomarkers allowing early diagnosis and progression are still needed. The aim of this study was to evaluate the methylation status of 12 cancer-related genes, namely ERCC1, hMLH1, ATM, CDKN2B (p15INK4B), p14ARF, CDKN2A (p16I...
Autores principales: | Majchrzak-Celińska, Aleksandra, Paluszczak, Jarosław, Szalata, Marlena, Barciszewska, Anna-Maria, Nowak, Stanisław, Baer-Dubowska, Wanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534508/ https://www.ncbi.nlm.nih.gov/pubmed/25648363 http://dx.doi.org/10.1007/s00432-015-1930-5 |
Ejemplares similares
-
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2013) -
Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2015) -
DNA methylation analysis with methylation‐sensitive high‐resolution melting (MS‐HRM) reveals gene panel for glioma characteristics
por: Majchrzak‐Celińska, Aleksandra, et al.
Publicado: (2020) -
ABCB1 Is Frequently Methylated in Higher-Grade Gliomas and May Serve as a Diagnostic Biomarker of More Aggressive Tumors
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2022) -
The negative regulators of Wnt pathway—DACH1, DKK1, and WIF1 are methylated in oral and oropharyngeal cancer and WIF1 methylation predicts shorter survival
por: Paluszczak, Jarosław, et al.
Publicado: (2014)